Apyx Medical Inc - Asset Resilience Ratio

Latest as of December 2019: 0.00%

Apyx Medical Inc (APYX) has an Asset Resilience Ratio of 0.00% as of December 2019. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check APYX strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

$0.00
Cash + Short-term Investments

Total Assets

$84.68 Million
All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2012–2019)

This chart shows how Apyx Medical Inc's Asset Resilience Ratio has changed over time. See Apyx Medical Inc (APYX) net asset quality to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Apyx Medical Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Apyx Medical Inc stock valuation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $0.00 0%
Total Liquid Assets $0.00 0.00%

Asset Resilience Insights

  • Limited Liquidity: Apyx Medical Inc maintains only 0.00% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company maintains a balanced mix of cash and short-term investments.

Apyx Medical Inc Industry Peers by Asset Resilience Ratio

Compare Apyx Medical Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Cochlear Ltd
AU:COH
Medical Devices 9.76%
Shenzhen New Industries Biomedical
SHE:300832
Medical Devices 9.95%
Jafron Biomedical Co Ltd
SHE:300529
Medical Devices 39.15%
HOB Biotech Group Corp Ltd
SHG:688656
Medical Devices 2.62%
Polynovo Ltd
AU:PNV
Medical Devices 0.04%
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
Medical Devices 10.88%
Dirui Industrial Co Ltd
SHE:300396
Medical Devices 6.89%
Emvision Medical Devices Ltd
AU:EMV
Medical Devices 0.06%

Annual Asset Resilience Ratio for Apyx Medical Inc (2012–2019)

The table below shows the annual Asset Resilience Ratio data for Apyx Medical Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2019-12-31 0.00% $0.00 $84.68 Million --
2018-12-31 64.51% $61.68 Million $95.61 Million +62.19pp
2017-12-31 2.32% $719.00K $30.99 Million +0.10pp
2016-12-31 2.22% $779.00K $35.11 Million -0.45pp
2015-12-31 2.67% $839.00K $31.45 Million +1.82pp
2014-12-31 0.85% $210.00K $24.83 Million -2.01pp
2013-12-31 2.86% $948.00K $33.18 Million +0.32pp
2012-12-31 2.53% $714.00K $28.18 Million --
pp = percentage points

About Apyx Medical Inc

NASDAQ:APYX USA Medical Devices
Market Cap
$176.29 Million
Market Cap Rank
#17151 Global
#3994 in USA
Share Price
$4.21
Change (1 day)
+1.45%
52-Week Range
$1.75 - $4.86
All Time High
$17.40
About

Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and … Read more